International Cannabis Weekly: 438

CANNABIS EUROPA PARIS 2026: FRANCE’S MEDICAL CANNABIS REIUMBURSEMENT PLANS REVEALED

Today (February 19, 2026), Cannabis Europa returns to the French capital for the first time since 2019 at a critical juncture for the incoming French medical cannabis industry.  Just the evening before, French authorities met with industry stakeholders to present the first draft of the country’s long-awaited medical cannabis reimbursement framework, the final regulatory piece needed to move France from pilot programme to permanent market.

READ MORE  »

ORGANIGRAM ACQUIRES SANITY GROUP IN LANDMARK €250M DEAL

READ MORE »

GERMAN RESEARCHERS PUBLISH FINDINGS ON SHORT-TERM EFFECTS OF CANNABIS LAW

READ MORE »

• A new milestone for CBD as EFSA sets safety threshold for novel food applications.
• Political party Die Linke has called for complete cannabis legalisation in Germany.
• North Macedonia to inspect all licensed medical cannabis producers after drug raids.
• Hemp is being explored as potential solution to combat PFAS pollution in Ghent.
• AI has emerged as last refuge for struggling cannabis companies seeking revival.
• Poland medical cannabis market data shows full post-ban recovery, with a catch.

VIEW REPORT »

• Virginia governor proclaims retail cannabis market framework following earlier legislative approval.
• Massachusetts surpasses $9 billion in recreational cannabis sales amid surge ahead of major snowstorm.
• Florida cannabis campaign asks Supreme Court to restore 71,000 rejected legalisation ballot signatures.
• Nebraska excluded from congressional medical cannabis protections prohibiting Department of Justice interference.
• High cannabis taxes push Connecticut consumers to purchase products across state lines in Massachusetts.
• Innovia Consulting acquires 365Vertical and 365 Cannabis to expand Microsoft-focused industry applications portfolio.
• Oklahoma House and Senate GOP leaders dismiss governor’s proposal to repeal medical cannabis at the ballot.
• West Virginia lawmaker seeks to allocate unused medical cannabis revenue amid federal law concerns.

• PAX has made a return to Canada with the new launch of TRIP all-in-one vape device.
• Decibel extends debt as Canadian licensed producer navigates financial pressures.
• Canadian industry and healthcare providers divided over regulating CBD as a natural health product.
• Canadabis Capital announces results of shareholders meeting on corporate matters.
• Nextleaf Solutions completes initial softgel shipment to Australia and expands global commercial partners programme.
• NORML Canada has made claims that the recent cannabis petition lacks supporting evidence.

• Universities and institutions expand options for studying cannabis in Argentina.
• Canntiva NGO marks four years supporting access to medical cannabis and challenging stigma in San Juan.
• Brazilian Senate broadens debate on medical cannabis and discusses domestic cultivation.
• Argentine executive leads Greenmed laboratory focused on cannabis-based medicines.

• Argent Biopharma reports falling revenues and rising costs ahead of AusCann deal.
• Somai partners with Japan’s Kiseki to introduce Japanese-quality medical cannabis to global markets.
• LGP and Cannatrek have decided to move forward with proposed merger in Australia.
• Pakistan Senate has passed amendment bill to strengthen Cannabis Control Authority.

• Private cannabis club BudBox steps out of the shadows to sponsor Africa’s premier cannabis event.
• Industry stakeholders are assessing implications of Ghana’s newly enacted cannabis laws